Press release
Now Available - Worldwide Fludeoxyglucose (18F) Radionuclide Injection Market Report 2017-2025
As the time it is injected in the body, it increase the glucose level under pathophysiological condition. Fludeoxyglucose F-18 transport and phosphorylation which is used to assess glucose metabolism. It rapidly distributed to all organs of the body after intravenous administration. Glucose metabolism of cancer cell is reflected by Fludeoxyglucose F-18 as it accumulated under Positron Emission Tomography (PET). Optimal PET imaging is generally achieved between 30 to 40 minutes after administration by Fludeoxyglucose (18F) radionuclide injection. Depending on tumor type, stage, and location, fludeoxyglucose F-18 accumulation may be increased, normal, or decreased. Fludeoxyglucose F-18 Injection are generally stored at 25°C (77°F); excursions permitted to 15-30°C in a lead shielded container.
Request for Report TOC @ https://www.persistencemarketresearch.com/toc/17275
Advancement in radiopharmaceutical technologies along with more improve hardware and software of PET imaging are the primary factors driving the growth of Fludeoxyglucose (18F) Radionuclide Injection market. Moreover improved accuracy in diagnostic and low risk associated with this injection will also responsible for the robust growth of Fludeoxyglucose (18F) Radionuclide Injection market. Rising prevalence of cancer and cardiovascular diseases will also significantly drive the growth of this market. The focus of leading market player to collaborate with local and regional player will be absolute opportunity for the growth of this Fludeoxyglucose (18F) Radionuclide Injection market. The high cost of Fludeoxyglucose (18F) Radionuclide Injection will restrain the growth of this market. The lack of availability of skilled professional in low economic countries will also hamper the growth of this market.
Fludeoxyglucose (18F) Radionuclide Injection market is expected to show significant growth over the forecast period due to increasing prevalence of cancer globally. According to World Health Organization, 14.1 Mn cases registered in 2012 of cancer globally. WHO also stated that more than 33% cancer cases are associated with smoking and chewing tobacco. The global market of Fludeoxyglucose (18F) Radionuclide Injection can be classified on the basis of indication and end-user. By indication Fludeoxyglucose (18F) Radionuclide Injection market can be classified as cancer, coronary artery disease and other. By end user Fludeoxyglucose (18F) Radionuclide Injection market is classified as hospital, clinics, and diagnostic centers. Among end user, hospitals are expected to gain maximum value share over the forecast period, and diagnostic centers are projected to grow at highest CAGR.
Global Fludeoxyglucose (18F) Radionuclide Injection market is classified in five key regions viz. North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. North America is expected to dominate the global Fludeoxyglucose (18F) Radionuclide Injection market due to high healthcare infrastructure. After North America, Fludeoxyglucose (18F) Radionuclide Injection market is then followed by Europe and Asia-Pacific. Europe market is expected to grow due to rise in the number of manufacturing companies of Fludeoxyglucose (18F) Radionuclide Injection. In Asia-Pacific, India and China are expected to be major market owing to increasing geriatric population and cancer incidences.
Request for Report Sample @ https://www.persistencemarketresearch.com/samples/17275
Some of the market participants in fludeoxyglucose (18F) radionuclide infection market identified across the value chain includes Zevacor Pharma, Inc., Queen’s PET Imaging Center, LLC, Triad Isotopes, Inc., NCM USA Bronx LLC, Spectron MRC, LLC, Petnet Solutions, Inc, Shertech Laboratories, LLC, Precision Nuclear LLC.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.
Contact Us
Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
Tel: +1-646-568-7751
Tollfree: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Website: https://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Now Available - Worldwide Fludeoxyglucose (18F) Radionuclide Injection Market Report 2017-2025 here
News-ID: 762968 • Views: …
More Releases from Persistence Market Research
Blood Collection Tubes Market Size, Growth, Share & Trends 2025-2032 | Global In …
The blood collection tubes market plays a pivotal role in modern healthcare by enabling safe, efficient, and accurate collection, storage, and transportation of blood samples. Extensively used in diagnostic laboratories, hospitals, and research centers, these tubes are critical for hematology, biochemistry, immunology, and molecular testing. They help maintain sample integrity, minimize contamination risks, and streamline laboratory workflows, making them indispensable in clinical diagnostics.
Request a Sample:
https://www.persistencemarketresearch.com/samples/35126
Market Overview
According to a recent study…
Frozen Pastries Market to Reach $3.8 Bn by 2032 Driven by Convenience and Ready- …
The global frozen pastries market is set for consistent expansion over the next decade, driven by the growing demand for convenient, ready-to-bake bakery products and evolving consumer lifestyles. According to market projections, the global frozen pastries market size is likely to be valued at US$ 2.6 billion in 2025 and is estimated to reach US$ 3.8 billion by 2032, growing at a CAGR of 5.7% during the forecast period from…
Cookies Market to Reach US$ 54.4 Bn by 2032 Driven by Rising Demand for Premium …
The global cookies market is witnessing steady growth, with its valuation expected to reach US$ 38.3 billion in 2025. According to projections, the market is set to rise significantly and reach approximately US$ 54.4 billion by 2032, expanding at a compound annual growth rate (CAGR) of 5.1% between 2025 and 2032. This growth trajectory is fueled by evolving consumer lifestyles, increasing demand for convenient and on-the-go snacks, and the rising…
Flaxseeds Market Growth Driven by Health Trends | Valued at US$ 1,284.7 Mn in 20 …
The global flaxseeds market is witnessing substantial expansion, driven by the growing consumer awareness of health benefits associated with flaxseed consumption and its increasing use across diverse industries such as food and beverages, pharmaceuticals, and cosmetics. According to recent industry analysis, the global flaxseeds market size is likely to be valued at US$ 1,284.7 million in 2025, and is projected to reach US$ 2,145.3 million by 2032, expanding at a…
More Releases for Fludeoxyglucose
Future of the Radiotheranostics Market: Strategic Analysis and Forecast to 2034
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Radiotheranostics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the last few years, we have seen a significant expansion in the radiotheranostics market. The market value is forecasted to increase from $8.79 billion in 2024 to reach a value of $10.07 billion in 2025,…
Radiotheranostics Industry Report 2025-2034: Market Dynamics, Trends, And Foreca …
The Radiotheranostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Radiotheranostics Market Size During the Forecast Period?
In the past few years, the market size of radiotheranostics has expanded quickly. Projected growth from $8.79 billion in 2024 to $10.07 billion in 2025,…
Medical Silk Fibroin Market Outlook: Expected Market Value of USD 12.1 Billion b …
Medical Silk Fibroin Market Overview
The Medical Silk Fibroin Market was valued at USD 4.12 Bn in 2024. It is expected to reach USD 12.1 Bn by 2032, with a CAGR of 14.42% during the forecast period from 2025 to 2032.
The Medical Silk Fibroin Market is gaining momentum due to the increasing demand for biocompatible and biodegradable materials in various medical applications. Silk fibroin, derived from silkworms, is recognized for its…
Global Fludeoxyglucose 18F Radionuclide Injection Market Size & Share Analysis - …
Market Overview and Report Coverage
Fludeoxyglucose 18F Radionuclide Injection is a radioactive tracer used in positron emission tomography (PET) scans to detect and localize abnormal cellular activity within the body, particularly in cancer cells. It is a glucose analog labeled with the radionuclide fluorine-18, allowing for precise imaging of metabolic processes.
The Fludeoxyglucose 18F Radionuclide Injection Market is expected to witness significant growth in the coming years. With increasing prevalence of cancer…
Communications and Media Software Market Sluggish Growth Rate Foreseen by 2021-2 …
This Communications and Media Software market analysis looks at the global market's current state and projected expansion from 2021 to 2027. It includes a summary of marketing research methodology as well as commercial potential. In this market study, the firms' static and dynamic characteristics have been merged. This research report looks at competitive business dynamics in order to truly comprehend worldwide. Major key drivers, a market synopsis, trade volume, and…
Europe to Lead the Fludeoxyglucose Radionuclide Injection market from the Front …
Fludeoxyglucose (18F) radionuclide injection is radioactive substance used for diagnostic purpose with Positron Emission Tomography (PET). This injection are basically used for diagnosis of cancer and coronary artery disease. 2-deoxy-2-[18F] fluoro-D-g1ucose is the active ingredients in the fludeoxyglucose (18F) radionuclide injection and it is administered by intravenous method. As the time it is injected in the body, it increase the glucose level under pathophysiological condition. Fludeoxyglucose F-18 transport…
